rs968701
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002827.4(PTPN1):c.702+82G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.514 in 1,156,644 control chromosomes in the GnomAD database, including 156,281 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.46 ( 17115 hom., cov: 32)
Exomes 𝑓: 0.52 ( 139166 hom. )
Consequence
PTPN1
NM_002827.4 intron
NM_002827.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.696
Publications
10 publications found
Genes affected
PTPN1 (HGNC:9642): (protein tyrosine phosphatase non-receptor type 1) The protein encoded by this gene is the founding member of the protein tyrosine phosphatase (PTP) family, which was isolated and identified based on its enzymatic activity and amino acid sequence. PTPs catalyze the hydrolysis of the phosphate monoesters specifically on tyrosine residues. Members of the PTP family share a highly conserved catalytic motif, which is essential for the catalytic activity. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP has been shown to act as a negative regulator of insulin signaling by dephosphorylating the phosphotryosine residues of insulin receptor kinase. This PTP was also reported to dephosphorylate epidermal growth factor receptor kinase, as well as JAK2 and TYK2 kinases, which implicated the role of this PTP in cell growth control, and cell response to interferon stimulation. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2013]
PTPN1 Gene-Disease associations (from GenCC):
- autoinflammatory syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.606 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.463 AC: 70371AN: 151912Hom.: 17116 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
70371
AN:
151912
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.521 AC: 523879AN: 1004616Hom.: 139166 AF XY: 0.526 AC XY: 264708AN XY: 503586 show subpopulations
GnomAD4 exome
AF:
AC:
523879
AN:
1004616
Hom.:
AF XY:
AC XY:
264708
AN XY:
503586
show subpopulations
African (AFR)
AF:
AC:
6606
AN:
22734
American (AMR)
AF:
AC:
12407
AN:
23864
Ashkenazi Jewish (ASJ)
AF:
AC:
9968
AN:
18876
East Asian (EAS)
AF:
AC:
21912
AN:
34230
South Asian (SAS)
AF:
AC:
39591
AN:
62964
European-Finnish (FIN)
AF:
AC:
24361
AN:
44962
Middle Eastern (MID)
AF:
AC:
1900
AN:
3236
European-Non Finnish (NFE)
AF:
AC:
384176
AN:
749530
Other (OTH)
AF:
AC:
22958
AN:
44220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
12578
25156
37735
50313
62891
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10012
20024
30036
40048
50060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.463 AC: 70387AN: 152028Hom.: 17115 Cov.: 32 AF XY: 0.466 AC XY: 34623AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
70387
AN:
152028
Hom.:
Cov.:
32
AF XY:
AC XY:
34623
AN XY:
74300
show subpopulations
African (AFR)
AF:
AC:
12419
AN:
41478
American (AMR)
AF:
AC:
7630
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1857
AN:
3468
East Asian (EAS)
AF:
AC:
3213
AN:
5150
South Asian (SAS)
AF:
AC:
2980
AN:
4820
European-Finnish (FIN)
AF:
AC:
5656
AN:
10548
Middle Eastern (MID)
AF:
AC:
189
AN:
294
European-Non Finnish (NFE)
AF:
AC:
34867
AN:
67964
Other (OTH)
AF:
AC:
1052
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1872
3744
5616
7488
9360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
660
1320
1980
2640
3300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2051
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.